MANKINDBSEMANKIND PHARMA LIMITEDHighNeutral
Announced Sat, 11 Jul · 13:23 IST

Mankind Pharma divests hospitality arm, sets up Dutch R&D arm

Strategic Transactions View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹2528.00
prior close
₹2525.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.8-0.9-0.9-0.1+0.5+0.9-1.9+1.9+0.4
Up moveDown movePending
AI summary

Board approved two moves: (1) Sale of 100 percent stake in wholly owned subsidiary Broadway Hospitality Services to AKRK Projects LLP for Rs 49 crore. Buyer is not a related party. Broadway is a non-core hospitality asset contributing about 0.07 percent of company revenue and 0.24 percent of net worth. Deal expected to close in 90 days. (2) Incorporation of a wholly owned subsidiary in Netherlands as an SPV for R&D investments and business development in niche therapies, with up to 5 million euro planned investment.

Likely market impact

Mildly positive. Clean-up of non-core hospitality arm refocuses the group on pharma. Dutch unit signals intent to expand into niche therapy R&D. Material size impact is small.